NAPRODOX 1 vial (Doxorubicin 50mg)

• Breast cancer
  
  
• Acute and chronic leukaemia
  
  
• Non-Hodgkin’s lymphomas
  
  
• Soft tissue and bone sarcomas
  
  
• Ovarian, lung, stomach and other solid tumours

Solution is prepared and administered intravenously in hospital settings under medical supervision. Dosage is adjusted individually based on diagnosis, treatment protocol and body weight.

Contraindications:

• Hypersensitivity to doxorubicin
  
  
• Severe liver impairment
  
  
• Severe cardiac failure
  
  
• Pregnancy and breastfeeding
  
  
• Bone marrow suppression
  
  

Side effects:

• Nausea, vomiting, hair loss
  
  
• Bone marrow suppression (anaemia, thrombocytopenia, leukopenia)
  
  
• Cardiotoxicity (arrhythmias, decreased ejection fraction)
  
  
• Local reactions (phlebitis, necrosis in case of extravasation)
  
  
• Immunosuppression and infection risk